Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 36: 888-891, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boerman, O. C.
Right arrow Articles by Thomas, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boerman, O. C.
Right arrow Articles by Thomas, C. M.

Clinical Chemistry, Vol 36, 888-891, Copyright © 1990 by American Association for Clinical Chemistry

Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay

OC Boerman, MF Segers, LG Poels, P Kenemans and CM Thomas
Department of Cell Biology & Histology, University of Nijmegen, The Netherlands.

An in-house OC 125 monoclonal antibody-based "sandwich" immunofluorometric assay (IFMA) described previously (Clin Chem 1987; 33:2191-4) gave higher results for CA 125 in 37 of 123 serum samples than did a commercially available immunoradiometric assay (IRMA). Discordant results between the two assays became concordant when measurements of the samples were repeated with normal mouse serum (100 mL/L) included in the IFMA reagent. The murine immunoglobulins are thought to block the ability of the heterophilic antibodies in the human serum samples to cross-link the labeled antibody with the solid- phase antibody. Using an enzyme immunoassay, we demonstrated human anti- mouse antibodies (HAMA) in most of the discordant samples examined. We tested the ability of nonimmune sera from other animal species to lower the apparent CA 125 concentrations of the spurious samples and observed that rat, goat, and sheep serum were less effective than mouse serum. One serum sample was discovered to give a falsely increased CA 125 result with the IRMA, but this increase could be prevented by adding murine serum to the IRMA reagent. We conclude that falsely increased CA 125 results are best prevented by adding murine serum (or murine antibodies) to the assay buffer.


The following articles in journals at HighWire Press have cited this article:


Home page
CVIHome page
T. B. Martins, B. M. Pasi, C. M. Litwin, and H. R. Hill
Heterophile Antibody Interference in a Multiplexed Fluorescent Microsphere Immunoassay for Quantitation of Cytokines in Human Serum
Clin. Vaccine Immunol., March 1, 2004; 11(2): 325 - 329.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. A.A. Ismail, P. L. Walker, J. H. Barth, K. C. Lewandowski, R. Jones, and W. A. Burr
Wrong Biochemistry Results: Two Case Reports and Observational Study in 5310 Patients on Potentially Misleading Thyroid-stimulating Hormone and Gonadotropin Immunoassay Results
Clin. Chem., November 1, 2002; 48(11): 2023 - 2029.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
R. L. Bertholf, L. Johannsen, and G. Benrubi
False Elevation of Serum CA-125 Level Caused by Human Anti-Mouse Antibodies
Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 414 - 418.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J.-M. Bidart, F. Thuillier, C. Augereau, J. Chalas, A. Daver, N. Jacob, F. Labrousse, and H. Voitot
Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
Clin. Chem., October 1, 1999; 45(10): 1695 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. J. Kricka
Human Anti-Animal Antibody Interferences in Immunological Assays
Clin. Chem., July 1, 1999; 45(7): 942 - 956.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. F. Fitzmaurice, C. Brown, N. Rifai, A. H. B. Wu, and K.-T. J. Yeo
False Increase of Cardiac Troponin I with Heterophilic Antibodies
Clin. Chem., October 1, 1998; 44(10): 2212 - 2214.
[Full Text] [PDF]


Home page
CVIHome page
N. Desem and S. L. Jones
Development of a Human Gamma Interferon Enzyme Immunoassay and Comparison with Tuberculin Skin Testing for Detection of Mycobacterium tuberculosis Infection
Clin. Vaccine Immunol., July 1, 1998; 5(4): 531 - 536.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
N. Despres and A. M. Grant
Antibody interference in thyroid assays: a potential for clinical misinformation
Clin. Chem., March 1, 1998; 44(3): 440 - 454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.